Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Solulink Completes Equity Financing for HybriLink™ Antibody-Labeling Technology

Published: Friday, July 19, 2013
Last Updated: Friday, July 19, 2013
Bookmark and Share
New funding advances mission to provide flow cytometry users with a solution to the ‘missing color’ problem.

Solulink, Inc. announced the completion of a new round of equity financing. The funds will enable Solulink to accelerate the commercialization of its HybriLink ‘any antibody in any color’ labeling technology. The HybriLink technology satisfies flow cytometrists’ unmet needs and enables antibody suppliers to address market demand for greater flow cytometry multiplexing ease and convenience.

The HybriLink technology solves the ‘missing color’ problem: the inability to find the needed antibody labeled with the right fluorophore (color). Often, the desired combination is not commercially available. By providing a simple way to mix and match any fluorophore with any antibody on demand, just-in-time at the point-of-use, HybriLink dramatically streamlines the development and expansion of multicolor flow panels for flow cytometry research labs. Solulink believes that HybriLink’s ability to offer all antibodies in all fluorophores – including the next generation of emerging fluorophores – resolves a fundamental challenge in flow cytometry and will expand the overall flow cytometry reagents market size.

“With the HybriLink technology, antibodies are labeled with a tag and the fluorophores labeled with a complimentary tag. These two components are then combined to form the labeled antibody, ready to use with nearly 100% efficiency. Labeled-antibody providers can now supply tagged antibodies and complimentary tagged fluorophores, which allow the user to create an unlimited number of labeled antibodies,” said Solulink’s CEO, David McCarty.

“Solulink’s HybriLink technology simultaneously fulfills two increasingly critical needs in flow cytometry: HybriLink offers flow cytometrists an easy way to create, or optimize, multi-color flow panels on demand by labeling any antibody with any color, without chemistry or chromatography. In addition, HybriLink offers strategic partners a radically simplified way to introduce new fluorophores into their library of labeled antibodies, while expanding their market potential.”

The company is currently providing early access to HybriLink products to select customers. Attractive licensing terms are available for licensees and commercial partners in the flow cytometry and antibody reagents markets.

“Flow cytometry instruments and fluorophores have advanced rapidly; however, antibody-labeling technology has stagnated and the few advances have not met user or market expectations,” added Mark Horne, CEO, Plymouth Ventures. “Based on our diligence results, we are confident that the HybriLink technology represents a major advancement for flow cytometry and will be embraced by the research community.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Former Life Technologies and BD Biosciences Executive John L. “Kip” Miller Joins Solulink’s Board of Directors
Mr. Miller brings a successful track record of life science leadership and in-depth knowledge of the life science and flow cytometry markets to Solulink’s Board.
Wednesday, September 04, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos